Dr David Greene Arizona | R3 Stem Cell Transplant Found To Reduce MS Relapses
According to the researchers such as Dr. David Greene, these results compare favorably to those obtained with various disease-modifying therapies (DMTs) for MS. AHSCT may need to be considered before several second-generation DMTs due to its higher efficacy in establishing long-term suppression of disease activity to save time and stop the irreversible progression of the disease.
